Indeed, the E2 turnover rate was markedly increased by CYP1A2, as the overexpression of CYP1A2 significantly reduced the level of E2 but elevated the level of E2 metabolite 2-ME which possesses a well-known anti-HCC property [20,42–44]. The gene discussed is CYP1A2; the disease is hepatocellular carcinoma.